NCT01585623View on ClinicalTrials.gov

Drug Interaction Study of SAR302503 in Patients With Solid Tumor

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Solid Tumor
Interventions
DRUG

SAR302503

"Pharmaceutical form:capsule~Route of administration: oral"

DRUG

omeprazol

"Pharmaceutical form:capsule~Route of administration: oral"

DRUG

metoprolol

"Pharmaceutical form:tablet~Route of administration: oral"

DRUG

midazolam

"Pharmaceutical form:solution~Route of administration: oral"

Trial Locations (3)

19111

Investigational Site Number 840002, Philadelphia

30912

Investigational Site Number 840004, Augusta

48201

Investigational Site Number 840001, Detroit

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT01585623 - Drug Interaction Study of SAR302503 in Patients With Solid Tumor | Biotech Hunter | Biotech Hunter